Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan-Reference-Cited by-同舟云学术

Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan

Published:2010-06 Issue:1-2 Volume:293 Page:82-86
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Miyake Yoshihiro,Tanaka Keiko,Fukushima Wakaba,Sasaki Satoshi,Kiyohara Chikako,Tsuboi Yoshio,Yamada Tatsuo,Oeda Tomoko,Miki Takami,Kawamura Nobutoshi,Sakae Nobutaka,Fukuyama Hidenao,Hirota Yoshio,Nagai Masaki

Funder

Ministry of Health, Labour, and Welfare, Japan

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference47 articles.

1. Risk factors for non-fatal acute myocardial infarction in middle-aged and older Japanese;Miyake;Jpn Circ J,2000

2. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population;Circ J,2006

3. Diabetes mellitus and the risk of dementia: the Rotterdam Study;Ott;Neurology,1999

4. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study;Kivipelto;BMJ,2001

5. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function;Arvanitakis;Arch Neurol,2004

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between type 2 diabetes mellitus and Parkinson's disease; a systematic review and meta-analysis;Brain Disorders;2024-09

2. Association of metabolic syndrome and its components with Parkinson’s disease: a cross-sectional study;BMC Endocrine Disorders;2024-06-19

3. Causal relationship between diabetes mellitus, glycemic traits and Parkinson’s disease: a multivariable mendelian randomization analysis;Diabetology & Metabolic Syndrome;2024-03-05

4. Effects of Metabolic Syndrome on Parkinson’s Disease and Nutraceutical Intervention Strategies;Parkinson’s Disease - Animal Models, Current Therapies and Clinical Trials;2023-12-20

5. Diabetes: a tipping point in neurodegenerative diseases;Trends in Molecular Medicine;2023-12